Gilead's filgotinib phase 3 hits primary endpoint but details dampen hopes

Gilead's filgotinib phase 3 hits primary endpoint but details dampen hopes ntaylor Thu, 05/21/2020 - 07:21

Gilead's filgotinib phase 3 hits primary endpoint but details dampen hopes
Gilead's filgotinib phase 3 hits primary endpoint but details dampen hopes ntaylor Thu, 05/21/2020 - 07:21